Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form ↓	Price
M05BA04	OSTEOMED	G	Alendronic acid (sodium alendronate) - 70mg	70mg	Tablet, scored	950,929 L.L
M01AB05	OLFEN-75 SR	G	Diclofenac sodium - 75mg	75mg	Tablet, prolonged release	326,554 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 10mg	10mg	Tablet, orodispersible	1,385,502 L.L
A04AA01	ONDANSETRON ARROW	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,280,682 L.L
A04AA01	ONZETRAN OD	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,023,880 L.L
N05AH03	OLANZAPINE ARROW	G	Olanzapine - 5mg	5mg	Tablet, orodispersible	1,385,502 L.L
N05AH03	OLANZAX 5	G	Olanzapine - 5mg	5mg	Tablet, mouth dissolving	1,316,966 L.L
N05AH03	OLANZAX 10	G	Olanzapine - 10mg	10mg	Tablet, mouth dissolving	2,329,327 L.L
M01AB05	OLFEN-50	G	Diclofenac sodium - 50mg	50mg	Tablet, gastroresistant	248,611 L.L
J01MA01	OFLACIN	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	602,041 L.L
J01MA01	OFLOMED	G	Ofloxacin - 200mg	200mg	Tablet, film-scored	601,530 L.L
G04CA02	OMNIC OCAS	B	Tamsulosin HCl - 0.4mg	0.4mg	Tablet, film coated, prolonged release	866,778 L.L
C10AA05	ORVASTA	G	Atorvastatin - 10mg	10mg	Tablet, film coated	834,526 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 750mg	750mg	Tablet, film coated	499,372 L.L
M04AA03	OXUBAT 120	G	Febuxostat - 120mg	120mg	Tablet, film coated	1,549,002 L.L
M04AA03	OXUBAT 80	G	Febuxostat - 80mg	80mg	Tablet, film coated	1,549,002 L.L
J01CA04	OSPAMOX	G	Amoxicillin (trihydrate) - 1g	1,000mg	Tablet, film coated	683,273 L.L
C02KX04	OPSUMIT	B	Macitentan - 10mg	10mg	Tablet, film coated	201,006,231 L.L
C10AA05	ORVASTA	G	Atorvastatin - 20mg	20mg	Tablet, film coated	920,532 L.L
M05BA07	OSTERAL	G	Risedronate sodium - 35mg	35mg	Tablet, film coated	511,940 L.L
C10AA05	ORVASTA	G	Atorvastatin - 40mg	40mg	Tablet, film coated	1,170,487 L.L
M05BX	OSSOPAN	B	Osseine-hydroxyapatite complex - 800mg	800mg	Tablet, film coated	1,142,266 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	710,893 L.L
C09CA08	OLMENOR	G	Olmesartan medoxomil - 10mg	10mg	Tablet, film coated	526,786 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	888,280 L.L
C09CA08	OLMENOR	G	Olmesartan medoxomil - 20mg	20mg	Tablet, film coated	667,890 L.L
C09CA08	OLMETEC	B	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	920,532 L.L
C09CA08	OLMENOR	G	Olmesartan medoxomil - 40mg	40mg	Tablet, film coated	721,643 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	791,523 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	565,758 L.L

...